AI assistant
LISATA THERAPEUTICS, INC. — Director's Dealing 2014
May 9, 2014
34931_dirs_2014-05-09_a1584fca-c6c6-4d97-8d11-7fe3b03e6fde.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2014-05-09
Reporting Person: Keirstead Hans (See Remarks)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-09 | Stock Options (right to purchase) | $4.92 | A | 45000 | Acquired | 2024-05-08 | Common Stock, par value $0.001 per share (45000) | Direct |
Footnotes
F1: On May 9, 2014 (the "Grant Date"), in connection with the commencement of the Reporting Person's employment with NeoStem, Inc. (the "Issuer"), the Reporting Person was granted an option (the "Option") to purchase an aggregate of 45,000 shares of the Issuer's common stock, par value $0.001 per share (the "Option Shares"), subject to all of the terms and conditions of the Issuer's 2009 Amended & Restated Equity Compensation Plan. The Option is scheduled to vest as to 15,000 Option Shares on each of May 9, 2015, May 9, 2016 and May 9, 2017, subject to the Reporting Person's continued employment.